Key Record Dates
ClinicalTrials.gov Identifier: | NCT03043547 |
---|---|
Brief Title: | Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies (NALIRICC) |
First Submitted : | January 26, 2017 |
First Submitted that Met QC Criteria : | February 2, 2017 |
First Posted : | February 6, 2017 (Estimate) |
Last Update Submitted that Met QC Criteria : | May 17, 2022 |
Last Update Posted : | May 18, 2022 |